Načítá se...
Suboptimal cotrimoxazole prophylactic concentrations in HIV‐infected children according to the WHO guidelines
AIMS: A clinical study was conduct in HIV‐infected children to evaluate the prophylactic doses of cotrimoxazole [sulfamethoxazole (SMX) and trimethoprim (TMP)] advised by the WHO. METHODS: Children received lopinavir‐based antiretroviral therapy with cotrimoxazole prophylaxis (200 mg of SMX/40 mg of...
Uloženo v:
| Vydáno v: | Br J Clin Pharmacol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698578/ https://ncbi.nlm.nih.gov/pubmed/28800382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13397 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|